Maurizio Martini, Tonia Cenci, Giorgio Quintino D'Alessandris, Valeriana Cesarini, Alessandra Cocomazzi, Lucia Ricci-Vitiani, Ruggero De Maria, Roberto Pallini and Luigi Maria Larocca Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis Cancer 119
Version of Record online: 6 NOV 2012 | DOI: 10.1002/cncr.27821
Id4 (inhibitor of DNA binding/differentiation type 4) epigenetic silencing identified a subgroup of glioblastoma with a favorable clinical outcome when treated with surgery followed by adjuvant radiotherapy and temozolomide. This effect may be due to involvement of Id4 in the MGP (matrix GLA protein)-mediated neoangiogenesis.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field